BB-12®

The BB-12® strain is tested in numerous clinical trials from newborn preterm infants to elderly in doses up to 100 billion CFU/day with no reported side effects.

BB-12® is furthermore GRAS (Generally Recognized As Safe) notified by FDA and approved by the Danish Medicines Agency as a Natural Health Product.

Health Area

Human studies have shown that BB-12® alone or in combinations has a beneficial effect within gastrointestinal health and immune health.

The Benefits of BB-12®

Studies indicate that BB-12®

  • Relieves constipation
  • Improves faecal properties and microbiota
  • Have positive effects against acute diarrhea
  • May reduce the risk of traveler’s diarrhea
  • Restores the intestinal microbiota after antibiotic treatment

Clinical Documentation

You will find abstracts of all the studies supporting these effects of BB-12® in our Selected Summaries. 

Studies furthermore indicate that BB-12® has an impact on colic and reduces risk of rotavirus diarrhea in infants. Studies are also published on its immune modulating effect.

All of the effects of the BB-12® strain makes it an excellent choice for a range of health areas, which you will also see from Chr. Hansen's probiotic product offerings handout (PDF, 461 KB).

Please contact our Sales Directors to learn more about your possibilities of using BB-12® in your probiotic product.

Downloads

BB-12® Selected Summaries
BB-12® Selected SummariesThis binder provides you with summaries of selected publications on Bifidobacterium BB-12®
BB-12® - Handout
BB-12® - HandoutChr. Hansen offers multiple application forms of one of our most clinically documented Probio-Tec®...